<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font18">for </span>
   <span class="font17">CPT </span>
   <span class="font17">with </span>
   <span class="font16">patients </span>
   <span class="font16">{background </span>
   <span class="font16">convalescent </span>
   <span class="font15">plasma </span>
   <span class="font15">COVIDâ€� </span>
   <span class="font15">studies </span>
   <span class="font14">margin </span>
   <span class="font14">The </span>
   <span class="font14">treatment </span>
   <span class="font14">{border-style </span>
   <span class="font14">(th </span>
   <span class="font14">was </span>
   <span class="font13">clinical </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">were </span>
   <span class="font13">from </span>
   <span class="font13">â€‰mL </span>
   <span class="font13">adverse </span>
   <span class="font12">(nâ€‰=â€‰) </span>
   <span class="font12">data </span>
   <span class="font12">After </span>
   <span class="font12">All </span>
   <span class="font12">al. </span>
   <span class="font12">antibody </span>
   <span class="font12">one </span>
   <span class="font12">received </span>
   <span class="font12">Negative </span>
   <span class="font12">doses </span>
   <span class="font12">mechanical </span>
   <span class="font12">respiratory </span>
   <span class="font12">that </span>
   <span class="font12">ventilation </span>
   <span class="font11">admission </span>
   <span class="font11">five </span>
   <span class="font11">has </span>
   <span class="font11">ill </span>
   <span class="font11">reported </span>
   <span class="font11">severe </span>
   <span class="font11">systematic </span>
   <span class="font11">â€� </span>
   <span class="font11">(nâ€‰=â€‰), </span>
   <span class="font11">;():â€�. </span>
   <span class="font11">Chest </span>
   <span class="font11">This </span>
   <span class="font11">after </span>
   <span class="font11">critically </span>
   <span class="font11">included </span>
   <span class="font11">neutralizing </span>
   <span class="font11">patients. </span>
   <span class="font11">px; </span>
   <span class="font11">review </span>
   <span class="font11">study </span>
   <span class="font11">within </span>
   <span class="font11">{font-family </span>
   <span class="font11">&amp;amp; </span>
   <span class="font11">April </span>
   <span class="font11">are </span>
   <span class="font11">d), </span>
   <span class="font11">disease </span>
   <span class="font11">during </span>
   <span class="font11">font-size </span>
   <span class="font11">health </span>
   <span class="font11">increased </span>
   <span class="font11">search </span>
   <span class="font11">studies. </span>
   <span class="font11">therapy </span>
   <span class="font11">titers </span>
   <span class="font11">transfusion </span>
   <span class="font11">COVIDâ€�. </span>
   <span class="font11">Health </span>
   <span class="font11">IgM </span>
   <span class="font11">Med </span>
   <span class="font11">Study </span>
   <span class="font11">acute </span>
   <span class="font11">all </span>
   <span class="font11">available </span>
   <span class="font11">been </span>
   <span class="font11">coronavirus </span>
   <span class="font11">diseases </span>
   <span class="font11">double; </span>
   <span class="font11">improved, </span>
   <span class="font11">nasal </span>
   <span class="font11">public </span>
   <span class="font11">viral </span>
   <span class="font11">Convalescent </span>
   <span class="font11">Discharged </span>
   <span class="font11">GGOs </span>
   <span class="font11">GGOs, </span>
   <span class="font11">IgG </span>
   <span class="font11">March </span>
   <span class="font11">Medical </span>
   <span class="font11">Symptoms </span>
   <span class="font11">absorption </span>
   <span class="font11">any </span>
   <span class="font11">authors </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">but </span>
   <span class="font11">case </span>
   <span class="font11">described </span>
   <span class="font11">high </span>
   <span class="font11">including </span>
   <span class="font11">influenza </span>
   <span class="font11">load </span>
   <span class="font11">not </span>
   <span class="font11">other </span>
   <span class="font11">our </span>
   <span class="font11">solid; </span>
   <span class="font11">symptoms </span>
   <span class="font11">syndrome </span>
   <span class="font11">this </span>
   <span class="font11">used </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(nâ€‰=â€‰). </span>
   <span class="font10">ARDS </span>
   <span class="font10">Accessed </span>
   <span class="font10">CPT, </span>
   <span class="font10">China </span>
   <span class="font10">Clin </span>
   <span class="font10">Critically </span>
   <span class="font10">ECMO </span>
   <span class="font10">February </span>
   <span class="font10">HTN </span>
   <span class="font10">ICU </span>
   <span class="font10">Organization </span>
   <span class="font10">Research </span>
   <span class="font10">SARSâ€�CoVâ€� </span>
   <span class="font10">Treatment </span>
   <span class="font10">Viral </span>
   <span class="font10">Virol. </span>
   <span class="font10">World </span>
   <span class="font10">addition, </span>
   <span class="font10">administered </span>
   <span class="font10">also </span>
   <span class="font10">antiâ€�SARSâ€�CoVâ€� </span>
   <span class="font10">approved </span>
   <span class="font10">arbidol, </span>
   <span class="font10">article </span>
   <span class="font10">articles </span>
   <span class="font10">between </span>
   <span class="font10">bias </span>
   <span class="font10">bold </span>
   <span class="font10">can </span>
   <span class="font10">cannula </span>
   <span class="font10">collab: </span>
   <span class="font10">conducted </span>
   <span class="font10">courier; </span>
   <span class="font10">databases </span>
   <span class="font10">distress </span>
   <span class="font10">dosage </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">events. </span>
   <span class="font10">evidence </span>
   <span class="font10">had </span>
   <span class="font10">identified </span>
   <span class="font10">interferon </span>
   <span class="font10">invasive </span>
   <span class="font10">limited </span>
   <span class="font10">patient </span>
   <span class="font10">patients, </span>
   <span class="font10">positive </span>
   <span class="font10">pt;} </span>
   <span class="font10">risk </span>
   <span class="font10">screened </span>
   <span class="font10">selected </span>
   <span class="font10">shortness </span>
   <span class="font10">such </span>
   <span class="font10">symptom </span>
   <span class="font10">titer </span>
   <span class="font10">trials </span>
   <span class="font10">two </span>
   <span class="font10">who </span>
  </p>
 </body>
</html>
